MBX Biosciences
MBX Biosciences is pioneering Precision Endocrine Peptide™ (PEP™) therapeutics to help people with endocrine disorders live fuller and healthier lives. Our mission is to restore health, simplify management and enable greater access for patients with endocrine diseases. The company’s lead product candidate for the treatment of hypoPARAthyroidism is currently in development and is designed to restore PTH physiology and correct the mineral imbalances to alleviate symptoms of the disorder. MBX is based in Carmel, Indiana. To learn more, please visit the company website at mbxbio.com and follow on LinkedIn and Twitter.
CANVUPARATIDE
Andrea's Constant Struggle with Hypoparathyroidism: A Story of Strength
Living with hypoparathyroidism is a constant challenge. Follow Andrea's journey as she works tirelessly to keep her calcium levels stable. From the demanding schedule of round-the-block supplements to the effects on her job, daily routines, and quality time with loved ones, Andrea's story is one of unwavering strength and determination. Watch and be inspired by her resilience.